Recent Advances on Nanotechnology Applications to Cancer Drug Therapy


  • Carolina Bellera Medicinal Chemistry, Department of Biological Sciences, Faculty of Exact Sciences, National University of La Plata (UNLP) – Argentinean National Council for Scientific and Technical Research (CONICET) - CCT La Plata - La Plata (B1900AJI), Buenos Aires, Argentina
  • Melisa E. Gantner Medicinal Chemistry, Department of Biological Sciences, Faculty of Exact Sciences, National University of La Plata (UNLP) – Argentinean National Council for Scientific and Technical Research (CONICET) - CCT La Plata - La Plata (B1900AJI), Buenos Aires, Argentina
  • María E. Ruiz Quality Control of Medications, Department of Biological Sciences, Faculty of Exact Sciences, National University of La Plata (UNLP), La Plata (B1900AJI), Buenos Aires, Argentina
  • Alan Talevi Medicinal Chemistry, Department of Biological Sciences, Faculty of Exact Sciences, National University of La Plata (UNLP) – Argentinean National Council for Scientific and Technical Research (CONICET) - CCT La Plata - La Plata (B1900AJI), Buenos Aires, Argentina



Anticancer Drug Therapy, Dendrimers, Inorganic Nanoparticles, Liposomes, Nanocapsules, Nanogels, Nanospheres.


 One of the greatest challenges in cancer drug therapy is to maximize the effectiveness of the active ingredient while reducing its systemic adverse effects. Conventional (non-targeted) systemic drug therapy is characterized by unspecific distribution of the anticancer drugs: both healthy and affected tissues are thus exposed to the chemotherapeutic agent, giving raise to off-target side-effects. Besides, a number of widely-used chemoterapeutic agents present unfavorable physicochemical properties, such as low solubility or low stability issues, limiting their available routes of administration and therapeutic applications. Nano-delivery systems seem as promising solutions to these issues. They can be used for targeted-drug release, diagnostic imaging and therapy monitoring. Nanosystems allow the formulation of drug delivery systems with tailored properties (e.g. solubility, biodegradability, release kinetics and distribution) that provide means to improve cancer patients' quality of life by lowering the administered dose and, incidentally, the cost of clinical treatments. This article overviews the main features of different nanovehicles (linear and non-linear polymeric nanosystems, lipid-based systems, inorganic nanoparticles) and presents a selection of reports on applications of such systems to cancer therapy published between 2010 and 2013.


Smith DA, Di L, Kerns EH. The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov 2010; 9: 929-39.

Ejendal KF, Hrycyna CA. Multidrug resistance and cancer: the role of the human ABC transporter ABCG2. Curr Protein Pept Sci 2002; 3: 503-11.

Lage H, Dietel M. Effect of the breast-cancer resistance protein on atypical multidrug resistance. Lancet Oncol 2000; 1: 169-75.

Marquez B, Van Bambeke F. ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions. Curr Drug Targets 2011; 12: 600-20.

Li S, Wang A, Jiang W, Guan Z. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles. BMC Cancer 2008; 8: 103.

Fassberg J, Stella VJ. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J Pharm Sci 1992; 81: 676-84.

Storniolo AM, Allerheiligen SR, Pearce HL. Preclinical, pharmacologic, and phase I studies of gemcitabine. Semin Oncol 1997; 24: 2-7.

Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer 2005; 41: 1955-68.

Hennenfent KL, Govindan R. Novel formulations of taxanes: a review. Old wine in a new bottle? Ann Oncol 2006; 17: 735-49.

Li S, Huang S, Peng SB. Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression. Int J Oncol 2005; 27: 1329-39.

Reubi JC. Old and new peptide receptor targets in cancer: future directions. Recent Results Cancer Res 2013; 194: 567-76.

Reubi JC. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 2003; 24: 389-427.

Zhou XB, Qiu Z, Liu XX, Zhang J, He YY, Wang XM, et al. The folate receptor α and Ovarian cancer. Chinese Journal of Pharmaceutical Biotechnology 2012; 19: 458-461.

Hutchings CJ, Koglin M, Marshall FH. Therapeutic antibodies directed at G protein-coupled receptors. MAbs 2010; 2: 594-606.

Yu B, Tai HC, Xue W, Lee LJ, Lee RJ. Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol 2010; 27: 286-98.

Chacko RT, Ventura J, Zhuang J, Thayumanavan S. Polymer nanogels: a versatile nanoscopic drug delivery platform. Adv Drug Delivery Rev 2012; 64: 836-51.

Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 2001; 41: 189-207.

Maeda H. Macromolecular therapeutics in cancer treatment: The EPR effect and beyond. J Control Release 2012; 164: 138-144.

Maeda H, Nakamura H, Fang J. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Delivery Rev 2013; 65: 71-79.

Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 1999; 51: 691-743.

Juliano RL. Factors affecting the clearance kinetics and tissue distribution of liposomes, microspheres and emulsions. Adv Drug Delivery Rev 1988; 2: 31-54.

Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Delivery Rev 2012; 64, Supplement: 24-36.

Rodrigues Jr JM, Fessi H, Bories C, Puisieux F, Devissaguet Jp. Primaquine-loaded poly(lactide) nanoparticles: physicochemical study and acute tolerance in mice. Int J Pharm 1995; 126: 253-260.

Bender AR, von Briesen H, Kreuter J, Duncan IB, Rubsamen-Waigmann H. Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/ macrophages in vitro. Antimicrob Agents Chemother 1996; 40: 1467-71.

Leroux J, Doelker E, Gurny R. The use of drug-loaded nanoparticles in cancer chemotherapy. In: Benita S, editors. Microencapsulation Methods and Industrial Applications. ed. New York: Marcel Dekker 1996; p. 535-575.

Bazile DV, Ropert C, Huve P, Verrecchia T, Marlard M, Frydman A, et al. Body distribution of fully biodegradable

Olivier JC, Huertas R, Lee HJ, Calon F, Pardridge WM. Synthesis of pegylated immunonanoparticles. Pharm Res 2002; 19: 1137-43.

Verrecchia T, Spenlehauer G, Bazile DV, Murry-Brelier A, Archimbaud Y, Veillard M. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. J Control Release 1995; 36: 49-61.

Stolnik S, Illum L, Davis SS. Long circulating microparticulate drug carriers. Adv Drug Delivery Rev 1995; 16: 195-214.

Storm G, Belliot SO, Daemen T, Lasic DD. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Delivery Rev 1995; 17: 31-48.

Lee JH, Kopecek J, Andrade JD. Protein-resistant surfaces prepared by PEO-containing block copolymer surfactants. J Biomed Mater Res 1989; 23: 351-68.

Gomes-da-Silva LC, Fonseca NA, Moura V, Pedroso de Lima MC, Simoes S, Moreira JN. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges. Acc Chem Res 2012; 45: 1163-71.

Matsumoto S, Christie RJ, Nishiyama N, Miyata K, Ishii A, Oba M, et al. Environment-responsive block copolymer micelles with a disulfide cross-linked core for enhanced siRNA delivery. Biomacromolecules 2009; 10: 119-27.

Nie Y, Gunther M, Gu Z, Wagner E. Pyridylhydrazone-based PEGylation for pH-reversible lipopolyplex shielding. Biomaterials 2011; 32: 858-69.

Takae S, Miyata K, Oba M, Ishii T, Nishiyama N, Itaka K, et al. PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors. J Am Chem Soc 2008; 130: 6001-9.

Yadav KS, Chuttani K, Mishra AK, Sawant KK. Effect of Size on the Biodistribution and Blood Clearance of Etoposide-Loaded PLGA Nanoparticles. PDA J Pharm Sci Technol 2011; 65: 131-9.

Letchford K, Burt H. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm 2007; 65: 259-69.

Pathak Y, Thassu D. Drug delivery nanoparticles formulation and characterization. 1st ed. New York: Informa Healthcare 2009.

Gad SC. Pharmaceutical manufacturing handbook: production and processes. 1st ed. New Jersey: Wiley-Interscience 2008.

Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Delivery Rev 2004; 56: 1649-1659.

Liu L, Li C, Li X, Yuan Z, An Y, He B. Biodegradable polylactide/poly(ethylene glycol)/polylactide triblock copolymer micelles as anticancer drug carriers. J Appl Polym Sci 2001; 80: 1976-1982.

Leslie EM, Deeley RG, Cole SPC. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 2005; 204: 216-237.

Semenas J, Allegrucci C, Boorjian SA, Mongan NP, Persson JL. Overcoming drug resistance and treating advanced prostate cancer. Curr Drug Targets 2012.

Murray S, Briasoulis E, Linardou H, Bafaloukos D, Papadimitriou C. Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies. Cancer Treat Rev 2012; 38: 890-903.

Gu W, Ma Y, Zhu C, Chen B, Ma J, Gao H. Synthesis of cross-linked carboxyl poly(glycerol methacrylate) and its application for the controlled release of doxorubicin. Eur J Pharm Sci 2012; 47: 556-63.

van Nostrum CF. Covalently cross-linked amphiphilic block copolymer micelles. Soft Matter 2011; 7: 3246-3259.

Lee H, Bae Y. Pharmaceutical differences between block copolymer self-assembled and cross-linked nanoassemblies as carriers for tunable drug release. Pharm Res 2012.

Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu Rev Med 2012; 63: 185-98.

Thassu D, Deleers M, Pathak Y. Nanoparticulate drug delivery systems. 1st ed. New York: Informa Healthcare 2007.

Torchilin VP. Nanoparticulates as drug carriers. 1st ed. London: Imperial College Press 2006.

Wang M, Thanou M. Targeting nanoparticles to cancer. Pharmacol Res 2010; 62: 90-99.

Hammady T, Rabanel J-M, Dhanikula RS, Leclair G, Hildgen P. Functionalized nanospheres loaded with anti-angiogenic drugs: Cellular uptake and angiosuppressive efficacy. Eur J Pharm Biopharm 2009; 72: 418-427.

Wuang SC, Neoh KG, Kang E-T, Pack DW, Leckband DE. HER-2-mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization. Biomaterials 2008; 29: 2270-2279.

Kamen BA, Smith AK. A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Delivery Rev 2004; 56: 1085-1097.

Garcia-Bennett A, Nees M, Fadeel B. In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy. Biochem Pharmacol 2011; 81: 976-984.

Shen Z, Li Y, Kohama K, Oneill B, Bi J. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres. Pharmacol Res 2011; 63: 51-58.

Zhao P, Wang H, Yu M, Liao Z, Wang X, Zhang F, et al. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: In vitro and in vivo evaluation. Eur J Pharm Biopharm 2012; 81: 248-256.

Saxena V, Naguib Y, Hussain MD. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer. Colloids Surf B Biointerfaces 2012; 94: 274-280.

Liang X, Sun Y, Liu L, Ma X, Hu X, Fan J, et al. Folate-functionalized nanoparticles for controlled ergosta-4,6,8(14),22-tetraen-3-one delivery. Int J Pharm 2013; 441: 1-8.

Chen J, Li S, Shen Q. Folic acid and cell-penetrating peptide conjugated PLGA–PEG bifunctional nanoparticles for vincristine sulfate delivery. Eur J Pharm Sci 2012; 47: 430-443.

Zhang L, Hou S, Mao S, Wei D, Song X, Lu Y. Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells. Int J Pharm 2004; 287: 155-162.

Ulbrich K, Michaelis M, Rothweiler F, Knobloch T, Sithisarn P, Cinatl J, et al. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells. Int J Pharm 2011; 406: 128-134.

Cirstoiu-Hapca A, Buchegger F, Bossy L, Kosinski M, Gurny R, Delie F. Nanomedicines for active targeting: Physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells. Eur J Pharm Sci 2009; 38: 230-237.

Colombo M, Corsi F, Foschi D, Mazzantini E, Mazzucchelli S, Morasso C, et al. HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches. Pharmacol Res 2010; 62: 150-165.

Arya G, Vandana M, Acharya S, Sahoo SK. Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy. Nanomedicine 2011; 7: 859-870.

Guo J, Gao X, Su L, Xia H, Gu G, Pang Z, et al. Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 2011; 32: 8010-8020.

Lee JH, Yigit MV, Mazumdar D, Lu Y. Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates. Adv Drug Delivery Rev 2010; 62: 592-605.

Min K, Jo H, Song K, Cho M, Chun Y-S, Jon S, et al. Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (−) prostate cancers. Biomaterials 2011; 32: 2124-2132.

Tong R, Yala L, Fan TM, Cheng J. The formulation of aptamer-coated paclitaxel–polylactide nanoconjugates and their targeting to cancer cells. Biomaterials 2010; 31: 3043-3053.

Shen J-M, Gao F-Y, Yin T, Zhang H-X, Ma M, Yang Y-J, et al. cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy. Pharmacol Res 2013; 70: 102-115.

Hu Q, Gu G, Liu Z, Jiang M, Kang T, Miao D, et al. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery. Biomaterials 2013; 34: 1135-1145.

Xia H, Gao X, Gu G, Liu Z, Hu Q, Tu Y, et al. Penetratin-functionalized PEG–PLA nanoparticles for brain drug delivery. Int J Pharm 2012; 436: 840-850.

Song Q, Yao L, Huang M, Hu Q, Lu Q, Wu B, et al. Mechanisms of transcellular transport of wheat germ agglutinin-functionalized polymeric nanoparticles in Caco-2 cells. Biomaterials 2012; 33: 6769-6782.

Wen Z, Yan Z, Hu K, Pang Z, Cheng X, Guo L, et al. Odorranalectin-conjugated nanoparticles: Preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration. J Control Release 2011; 151: 131-138.

Frutos G, Prior-Cabanillas A, París R, Quijada-Garrido I. A novel controlled drug delivery system based on pH-responsive hydrogels included in soft gelatin capsules. Acta Biomater 2010; 6: 4650-4656.

Gupta P, Vermani K, Garg S. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov Today 2002; 7: 569-579.

Patil S, Chaudhury P, Clarizia L, McDonald M, Reynaud E, Gaines P, et al. Responsive hydrogels produced via organic sol–gel chemistry for cell culture applications. Acta Biomater 2012; 8: 2919-2931.

Reis AV, Guilherme MR, Cavalcanti OA, Rubira AF, Muniz EC. Synthesis and characterization of pH-responsive hydrogels based on chemically modified Arabic gum polysaccharide. Polymer 2006; 47: 2023-2029.

Huynh CT, Nguyen MK, Lee DS. Biodegradable pH/temperature-sensitive oligo(β-amino ester urethane) hydrogels for controlled release of doxorubicin. Acta Biomater 2011; 7: 3123-3130.

Zhang J-T, Bhat R, Jandt KD. Temperature-sensitive PVA/PNIPAAm semi-IPN hydrogels with enhanced responsive properties. Acta Biomater 2009; 5: 488-497.

Zhao Z, Li Z, Xia Q, Xi H, Lin Y. Fast synthesis of temperature-sensitive PNIPAAm hydrogels by microwave irradiation. Eur Polym J 2008; 44: 1217-1224.

Ejaz M, Yu H, Yan Y, Blake DA, Ayyala RS, Grayson SM. Evaluation of redox-responsive disulfide cross-linked poly(hydroxyethyl methacrylate) hydrogels. Polymer 2011; 52: 5262-5270.

Oh JK, Siegwart DJ, Lee H-i, Sherwood G, Peteanu L, Hollinger JO, et al. Biodegradable Nanogels Prepared by Atom Transfer Radical Polymerization as Potential Drug Delivery Carriers: Synthesis, Biodegradation, in vitro Release, and Bioconjugation. J Am Chem Soc 2007; 129: 5939-5945.

Casolaro M, Casolaro I, Lamponi S. Stimuli-responsive hydrogels for controlled pilocarpine ocular delivery. Eur J Pharm Biopharm 2012; 80: 553-561.

Li H, Yew YK. Simulation of soft smart hydrogels responsive to pH stimulus: Ionic strength effect and case studies. Materials Science and Engineering: C 2009; 29: 2261-2269.

Chen J, Li H, Lam KY. Transient simulation for kinetic responsive behaviors of electric-sensitive hydrogels subject to applied electric field. Materials Science and Engineering: C 2005; 25: 710-712.

Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Delivery Rev 2012; 64, Supplement: 49-60.

Liu H, Wang C, Gao Q, Liu X, Tong Z. Magnetic hydrogels with supracolloidal structures prepared by suspension polymerization stabilized by Fe2O3 nanoparticles. Acta Biomater 2010; 6: 275-281.

Wang Y, Dong A, Yuan Z, Chen D. Fabrication and characterization of temperature-, pH- and magnetic-field-sensitive organic/inorganic hybrid poly (ethylene glycol)-based hydrogels. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2012; 415: 68-76.

Cheng R, Meng F, Deng C, Klok H-A, Zhong Z. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 2013; 34: 3647-3657.

Fleige E, Quadir MA, Haag R. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: Concepts and applications. Adv Drug Delivery Rev 2012; 64: 866-884.

Motornov M, Roiter Y, Tokarev I, Minko S. Stimuli-responsive nanoparticles, nanogels and capsules for integrated multifunctional intelligent systems. Prog Polym Sci 2010; 35: 174-211.

Toti US, Guru BR, Grill AE, Panyam J. Interfacial activity assisted surface functionalization: A novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery. Mol Pharm 2010; 7: 1108-1117.

Lieb E, Hacker M, Tessmar J, Kunz-Schughart LA, Fiedler J, Dahmen C, et al. Mediating specific cell adhesion to low-adhesive diblock copolymers by instant modification with cyclic RGD peptides. Biomaterials 2005; 26: 2333-2341.

Cho HS, Dong Z, Pauletti GM, Zhang J, Xu H, Gu H, et al. Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: A multifunctional nanocarrier system for cancer diagnosis and treatment. ACS Nano 2010; 4: 5398-5404.

Khoee S, Rahmatolahzadeh R. Synthesis and characterization of pH-responsive and folated nanoparticles based on self-assembled brush-like PLGA/PEG/AEMA copolymer with targeted cancer therapy properties: A comprehensive kinetic study. Eur J Med Chem 2012; 50: 416-427.

Sahu SK, Maiti S, Pramanik A, Ghosh SK, Pramanik P. Controlling the thickness of polymeric shell on magnetic nanoparticles loaded with doxorubicin for targeted delivery and MRI contrast agent. Carbohydr Polym 2012; 87: 2593-2604.

Kim JH, Li Y, Kim MS, Kang SW, Jeong JH, Lee DS. Synthesis and evaluation of biotin-conjugated pH-responsive polymeric micelles as drug carriers. Int J Pharm 2012; 427: 435-442.

K CR, Thapa B, Xu P. pH and redox dual responsive nanoparticle for nuclear targeted drug delivery. Mol Pharm 2012; 9: 2719-29.

Deng Z, Zhen Z, Hu X, Wu S, Xu Z, Chu PK. Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy. Biomaterials 2011; 32: 4976-86.

Zhao M, Hu B, Gu Z, Joo K-I, Wang P, Tang Y. Degradable polymeric nanocapsule for efficient intracellular delivery of a high molecular weight tumor-selective protein complex. Nano Today 2013; 8: 11-20.

Gu Z, Yan M, Hu B, Joo KI, Biswas A, Huang Y, et al. Protein nanocapsule weaved with enzymatically degradable polymeric network. Nano Lett 2009; 9: 4533-8.

Zhao M, Biswas A, Hu B, Joo KI, Wang P, Gu Z, et al. Redox-responsive nanocapsules for intracellular protein delivery. Biomaterials 2011; 32: 5223-30.

Tolstoy VP. Successive ionic layer deposition. The use in nanotechnology. Russ Chem Rev 2006; 75: 161-175.

Decher G. Fuzzy Nanoassemblies: Toward Layered Polymeric Multicomposites. Science 1997; 277: 1232-1237.

Keller SW, Kim H-N, Mallouk TE. Layer-by-Layer Assembly of Intercalation Compounds and Heterostructures on Surfaces: Toward Molecular "Beaker" Epitaxy. J Am Chem Soc 1994; 116: 8817-8818.

Fujii N, Fujimoto K, Michinobu T, Akada M, Hill JP, Shiratori S, et al. The Simplest Layer-by-Layer Assembly Structure: Best Paired Polymer Electrolytes with One Charge per Main Chain Carbon Atom for Multilayered Thin Films. Macromolecules 2010; 43: 3947-3955.

Lvov Y, Ariga K, Ichinose I, Kunitake T. Assembly of Multicomponent Protein Films by Means of Electrostatic Layer-by-Layer Adsorption. J Am Chem Soc 1995; 117: 6117-6123.

Lvov Y, Onda M, Ariga K, Kunitake T. Ultrathin films of charged polysaccharides assembled alternately with linear polyions. J Biomater Sci Polym Ed 1998; 9: 345-55.

Ariga K, Lvov Y, Ichinose I, Kunitake T. Ultrathin films of inorganic materials (SiO2 nanoparticle, montmorillonite microplate, and molybdenum oxide) prepared by alternate layer-by-layer assembly with organic polyions. Appl Clay Sci 1999; 15: 137-152.

Hammond PT. Form and Function in Multilayer Assembly: New Applications at the Nanoscale. Adv Mater 2004; 16: 1271-1293.

Tang Z, Wang Y, Podsiadlo P, Kotov NA. Biomedical Applications of Layer-by-Layer Assembly: From Biomimetics to Tissue Engineering. Adv Mater 2006; 18: 3203-3224.

De Geest BG, Sanders NN, Sukhorukov GB, Demeester J, De Smedt SC. Release mechanisms for polyelectrolyte capsules. Chem Soc Rev 2007; 36: 636-649.

Sukhorukov GB, Rogach AL, Garstka M, Springer S, Parak WJ, Munoz-Javier A, et al. Multifunctionalized polymer microcapsules: novel tools for biological and pharmacological applications. Small 2007; 3: 944-55.

Ariga K, Lvov YM, Kawakami K, Ji Q, Hill JP. Layer-by-layer self-assembled shells for drug delivery. Adv Drug Deliv Rev 2011; 63: 762-71.

De Koker S, De Cock LJ, Rivera-Gil P, Parak WJ, Auzely Velty R, Vervaet C, et al. Polymeric multilayer capsules delivering biotherapeutics. Adv Drug Deliv Rev 2011; 63: 748-61.

De Cock LJ, De Koker S, De Geest BG, Grooten J, Vervaet C, Remon JP, et al. Polymeric multilayer capsules in drug delivery. Angew Chem Int Ed Engl 2010; 49: 6954-73.

De Geest BG, Sukhorukov GB, Mohwald H. The pros and cons of polyelectrolyte capsules in drug delivery. Expert Opin Drug Deliv 2009; 6: 613-24.

Balabushevitch NG, Sukhorukov GB, Moroz NA, Volodkin DV, Larionova NI, Donath E, et al. Encapsulation of proteins by layer-by-layer adsorption of polyelectrolytes onto protein aggregates: factors regulating the protein release. Biotechnol Bioeng 2001; 76: 207-13.

Shen HJ, Shi H, Ma K, Xie M, Tang LL, Shen S, et al. Polyelectrolyte capsules packaging BSA gels for pH-controlled drug loading and release and their antitumor activity. Acta Biomater 2013; 9: 6123-33.

Xu W, Choi I, Plamper FA, Synatschke CV, Muller AH, Tsukruk VV. Nondestructive light-initiated tuning of layer-by-layer microcapsule permeability. ACS Nano 2013; 7: 598-613.

Li Y, Lu L, Zhang H, Wang J. The pH regulated phycobiliproteins loading and releasing of polyelectrolytes multilayer microcapsules. Colloids Surf B Biointerfaces 2012; 93: 121-6.

Wohl BM, Engbersen JF. Responsive layer-by-layer materials for drug delivery. J Control Release 2012; 158: 2-14.

Crouzier T, Szarpak A, Boudou T, Auzely-Velty R, Picart C. Polysaccharide-blend multilayers containing hyaluronan and heparin as a delivery system for rhBMP-2. Small 2010; 6: 651-62.

Zhou J, Romero G, Rojas E, Ma L, Moya S, Gao C. Layer by layer chitosan/alginate coatings on poly(lactide-co-glycolide) nanoparticles for antifouling protection and Folic acid binding to achieve selective cell targeting. J Colloid Interface Sci 2010; 345: 241-7.

Ochs CJ, Such GK, Yan Y, van Koeverden MP, Caruso F. Biodegradable click capsules with engineered drug-loaded multilayers. ACS Nano 2010; 4: 1653-63.

Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, et al. A New Class of Polymers: Starburst-Dendritic Macromolecules. Polym J 1985; 17: 117-132.

Tomalia DA. Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog Polym Sci 2005; 30: 294-324.

Bosman AW, Janssen HM, Meijer EW. About Dendrimers: Structure, Physical Properties, and Applications. Chem Rev 1999; 99: 1665-1688.

Buhleier E, Wehner W, VÖGtle F. "Cascade"- and "Nonskid-Chain-like" Syntheses of Molecular Cavity Topologies. Synthesis 1978; 1978: 155-158.




How to Cite

Carolina Bellera, Melisa E. Gantner, María E. Ruiz, & Alan Talevi. (2013). Recent Advances on Nanotechnology Applications to Cancer Drug Therapy . Journal of Cancer Research Updates, 2(3),  151–185.




Similar Articles

You may also start an advanced similarity search for this article.